Targeting MIF in Cancer: Therapeutic Strategies, Current Developments, and Future Opportunities

Medicinal Research Reviews
Ciaran O'ReillySeamas C Donnelly

Abstract

Strong evidence has been presented linking chronic inflammation to the onset and pathogenesis of cancer. The multifunctional pro-inflammatory protein macrophage migration inhibitory factor (MIF) occupies a central role in the inflammatory pathway and has been implicated in the tumorigenesis, angiogenesis, and metastasis of many cancer phenotypes. This review highlights the current state of the art, which presents MIF, and the second member of the MIF structural superfamily, D-DT (MIF2), as significant mediators in the inflammatory-cancer axis. Although the mechanism by which MIF asserts its biological activity has yet to be fully understood, it has become clear in recent years that for certain phenotypes of cancer, MIF represents a valid therapeutic target. Current research efforts have focused on small molecule approaches that target MIF's unique tautomerase active site and neutralization of MIF with anti-MIF antibodies. These approaches have yielded promising results in a number of preclinical murine cancer models and have helped to increase our understanding of MIF biological activity. More recently, MIF's involvement in a number of key protein-protein interactions, such as with CD74 and HSP90, has been highlighted and provi...Continue Reading

References

Jul 1, 1966·Proceedings of the National Academy of Sciences of the United States of America·J R David
Dec 15, 1993·Biochemical and Biophysical Research Communications·G OdhH Rorsman
Mar 1, 1996·Nature Structural Biology·M SuzukiM Sakai
May 28, 1996·Proceedings of the National Academy of Sciences of the United States of America·H W SunE Lolis
Jul 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·M BacherR Bucala
Dec 1, 1996·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·R Bucala
Jun 24, 1998·The Journal of Clinical Investigation·A G RossiS C Donnelly
Nov 6, 1998·The Journal of Experimental Medicine·H ChenH Metzger
Nov 24, 1999·The Journal of Experimental Medicine·J D HudsonD H Beach
Jan 5, 2002·Proceedings of the National Academy of Sciences of the United States of America·Robert A MitchellRichard Bucala
Jan 5, 2002·Proceedings of the National Academy of Sciences of the United States of America·Peter D SenterRichard Bucala
Jun 8, 2002·Current Pharmaceutical Design·Masaya OritaShigeo Fujita
Mar 14, 2003·The Journal of Pathology·Kar Neng LaiHui Yao Lan
Jun 5, 2003·The Journal of Experimental Medicine·Lin LengRichard Bucala
Jul 25, 2003·Proceedings of the National Academy of Sciences of the United States of America·G Fingerle-RowsonR Bucala
Sep 23, 2003·Nature Reviews. Immunology·Thierry Calandra, Thierry Roger
Jun 11, 2005·Cell Death and Differentiation·F TalosO Petrenko
Sep 24, 2005·American Journal of Respiratory and Critical Care Medicine·Barry J PlantSeamas C Donnelly
Sep 28, 2005·Proceedings of the National Academy of Sciences of the United States of America·Y MizueR Bucala
Apr 22, 2006·Nature Reviews. Drug Discovery·Eric F MorandJürgen Bernhagen
Jul 25, 2006·The Journal of Biological Chemistry·Arezoo DaryadelShida Yousefi
Dec 5, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Katherine L Meyer-SieglerPedro L Vera
Feb 10, 2007·The EMBO Journal·Alice NemajerovaOleksi Petrenko
Feb 24, 2007·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Jane V HigdonRoderick H Dashwood

❮ Previous
Next ❯

Citations

Jun 22, 2016·International Journal of Cardiology·Wan-Li ChengYi-Jen Chen
Sep 7, 2016·Vaccines·Saskia J A M SantegoetsSjoerd H van der Burg
Nov 5, 2016·Neurochemistry International·Gil BenedekHalina Offner
Mar 25, 2017·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Qingying WangJiawen Zhang
Dec 3, 2017·Molecular & Cellular Proteomics : MCP·Rupert L MayerChristopher Gerner
Sep 13, 2017·British Journal of Cancer·Mirazul IslamZubaidah Zakaria
Feb 10, 2019·The Journal of Immunology : Official Journal of the American Association of Immunologists·Mohammed HowaitAlexandru Movila
Aug 16, 2019·Expert Opinion on Therapeutic Targets·Joshua B BilsborrowRichard Bucala
Jan 16, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Maria Cristina PetraliaMaria Sofia Basile
Apr 14, 2020·Journal of Plastic Surgery and Hand Surgery·Bong-Sung KimGerrit Grieb
Sep 10, 2018·Biochemistry. Biokhimii︠a︡·A V SokolovV R Samygina
Nov 6, 2018·Frontiers in Pharmacology·Xinyu YangHongcai Shang
Mar 12, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Eugenio CavalliMaria Sofia Basile
Nov 16, 2016·Clinical and Experimental Medicine·Shuai LinZhijun Dai
Mar 28, 2019·Nature Reviews. Urology·Justin C PenticuffJohn A Taylor
Feb 8, 2019·Frontiers in Medicine·Aphrodite KapurniotuJürgen Bernhagen
Sep 24, 2020·International Journal of Inflammation·L AkhmaltdinovaA Turmukhambetova
May 18, 2018·Journal of Hematology & Oncology·Rachel E PiddockStuart A Rushworth
Aug 11, 2019·Cytokine·Stanislava Stošić-GrujičićIvana Stojanović
Jan 25, 2021·QJM : Monthly Journal of the Association of Physicians·Mauro VasellaBong-Sung Kim
Mar 30, 2021·Frontiers in Pharmacology·Yongjian WenWei Huang
May 21, 2020·Cell Chemical Biology·Georgios PantourisElias J Lolis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.